Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research from Comenius University has provided new data on breast cancer
January 8th, 2009
According to recent research from Martin, Slovakia, "Monotherapy with aromatase inhibitors has no established role in premenopausal breast cancer in women and is an area of future exploration. In this study, chemopreventive effects of anastrozole in the model of N-methyl-N-nitrosourea-induced premenopausal mammary carcinogenesis in female rats were evaluated." "Anastrozole was dietarily administered at two concentrations: 0.05 mg/kg (ANA 0.05) and 0.5 mg/kg (ANA 0.5). Basic parameters of experimental carcinogenesis and side-effects on selected organs after anastrozole treatment in animals were assessed. In the ANA 0.5 group, anastrozole suppressed tumor incidence by 40%...
Source: Women's Health Weekly (2009-01-08)
|
